Repository logo
 

Inflammation and cerebral small vessel disease: A systematic review

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Abstract

Inflammation is increasingly implicated as a risk factor for dementia, stroke, and small vessel disease (SVD). However, the underlying mechanisms and causative pathways remain unclear. We systematically reviewed the existing literature on the associations between markers of inflammation and SVD (i.e., white matter hyperintensities (WMH), lacunes, enlarged perivascular spaces (EPVS), cerebral microbleeds (CMB)) in cohorts of older people with good health, cerebrovascular disease, or cognitive impairment. Based on distinctions made in the literature, markers of inflammation were classified as systemic inflammation (e.g. C-reactive protein, interleukin-6, fibrinogen) or vascular inflammation/endothelial dysfunction (e.g. homocysteine, von Willebrand factor, Lp-PLA2). Evidence from 82 articles revealed relatively robust associations between SVD and markers of vascular inflammation, especially amongst stroke patients, suggesting that alterations to the endothelium and blood-brain barrier may be a driving force behind SVD. Conversely, cross-sectional findings on systemic inflammation were mixed, although longitudinal investigations demonstrated that elevated levels of systemic inflammatory markers at baseline predicted subsequent SVD severity and progression. Importantly, regional analysis revealed that systemic and vascular inflammation were differentially related to two distinct forms of SVD. Specifically, markers of vascular inflammation tended to be associated with SVD in areas typical of hypertensive arteriopathy (e.g., basal ganglia), while systemic inflammation appeared to be involved in CAA-related vascular damage (e.g., centrum semiovale). Nonetheless, there is insufficient data to establish whether inflammation is causal of, or secondary to, SVD. Findings have important implications on interventions, suggesting the potential utility of treatments targeting the brain endothelium and blood brain barrier to combat SVD and associated neurodegenerative diseases.

Keywords: small vessel disease; inflammation; stroke; endothelial dysfunction; white matter hyperintensities, lacunes, enlarged perivascular spaces, cerebral microbleeds

Description

Keywords

Cerebral microbleeds, Endothelial dysfunction, Enlarged perivascular spaces, Inflammation, Lacunes, Small vessel disease, Stroke, White matter hyperintensities, Adult, Aged, Aged, 80 and over, Animals, Blood-Brain Barrier, Brain, Cerebral Small Vessel Diseases, Cognitive Dysfunction, Female, Humans, Hypertension, Inflammation, Male, Middle Aged, Stroke

Journal Title

Ageing Research Reviews

Conference Name

Journal ISSN

1568-1637
1872-9649

Volume Title

53

Publisher

Elsevier BV
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Wellcome Trust (103838/Z/14/Z)
Acknowledgements This study is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) Dementia and Neurodegeneration Theme (Grant Reference Number 146281) ... James Rowe is supported by the Wellcome Trust (103838). Hugh Markus and John O’Brien are supported by NIHR Senior Investigator awards.